pd 169316 has been researched along with Breast Cancer in 2 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakari, M | 1 |
| Kanouchi, H | 1 |
| Oka, T | 1 |
| Daniel, KG | 1 |
| Anderson, JS | 1 |
| Zhong, Q | 1 |
| Kazi, A | 1 |
| Gupta, P | 1 |
| Dou, QP | 1 |
2 other studies available for pd 169316 and Breast Cancer
| Article | Year |
|---|---|
High dose of pyridoxine induces IGFBP-3 mRNA expression in MCF-7 cells and its induction is inhibited by the p53-specific inhibitor pifithrin-α.
Topics: Acetonitriles; Antineoplastic Agents; Apoptosis; Benzothiazoles; Breast Neoplasms; Cell Line, Tumor; | 2011 |
Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Autolysis; Breast Neoplasms; Calpain; Cytochrome c Group; Enzyme A | 2003 |